MIDAS

A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome

MomelotinibOngoingRecruitingPhase 2Open NCT06847867 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…